Gilead (GILD) Reaches Pricing Agreement with US Government to Lower Drug Costs

Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. Gilead (GILD) Reaches Pricing Agreement with US Government to Lower Drug Costs On December 19, Gilead Sciences, Inc. (NASDAQ:GILD) announced an agreement with the US government aimed at lowering drug costs for Americans. The move reinforces the company’s long-standing focus on US-based innovation, affordability, and global health leadership. Under the three-year agreement, Gilead agreed to all reques ...